Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000217622 | SCV000279381 | pathogenic | not provided | 2023-03-24 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 32144935, 28377535, 27848944, 31526516, 35893069, 36758276, 27839871) |
Genome Diagnostics Laboratory, |
RCV000625193 | SCV000744079 | pathogenic | Intellectual disability, autosomal dominant 6 | 2017-07-28 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625193 | SCV000745553 | likely pathogenic | Intellectual disability, autosomal dominant 6 | 2017-05-31 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV000625193 | SCV001335352 | likely pathogenic | Intellectual disability, autosomal dominant 6 | 2017-04-04 | criteria provided, single submitter | clinical testing | This variant was identified as de novo (maternity and paternity confirmed). |
Diagnostic Laboratory, |
RCV001260713 | SCV001437805 | pathogenic | Intellectual disability | 2020-09-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002519747 | SCV003441200 | pathogenic | Intellectual disability, autosomal dominant 6; Developmental and epileptic encephalopathy, 27 | 2022-07-09 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 751 of the GRIN2B protein (p.Ile751Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with intellectual disability (PMID: 28377535). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 234500). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GRIN2B protein function. For these reasons, this variant has been classified as Pathogenic. |
Genome |
RCV001265388 | SCV001443513 | pathogenic | Complex neurodevelopmental disorder | 2019-02-01 | no assertion criteria provided | provider interpretation | Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2019-02-01 and interpreted as Pathogenic. The reporting laboratory might also submit to ClinVar. This variant was identified in multiple probands enrolled in Simons Searchlight. |
Diagnostic Laboratory, |
RCV000217622 | SCV001741638 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000217622 | SCV001954761 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Molecular Genetics laboratory, |
RCV000217622 | SCV004031312 | pathogenic | not provided | 2023-03-29 | no assertion criteria provided | clinical testing |